Quality Control and Validation of Extracellular Vesicles Isolated from Cultured Human Breast Cancer Cells

Overview

Journal BMC Res Notes

Publisher Biomed Central

Specialties Biology
General Medicine

Date 2024 Jul 23

PMID 39044286

Authors

Urvi Patel

David Susman

Alison L Allan

Affiliations

Soon will be listed here.

Abstract

Objective: Extracellular vesicles (EVs) have been shown to play a critical role in promoting tumorigenesis. As EV research grows, it is of importance to have standardization of isolation, quality control, characterization and validation methods across studies along with reliable references to explore troubleshooting solutions. Therefore, our objective with this Research Note was to isolate EVs from multiple breast cancer cell lines and to describe and perform protocols for validation as outlined by the list of minimal information for studies of EVs (MISEV) from the International Society for Extracellular Vesicles.

Results: To isolate EVs, two techniques were employed: ultracentrifugation and size exclusion chromatography. Ultracentrifugation yielded better recovery of EVs in our hands and was therefore used for further validation. In order to satisfy the MISEV requirements, protein quantification, immunoblotting of positive (CD9, CD63, TSG101) and negative (TGFβ1, β-tubulin) markers, nanoflow cytometry and electron microscopy was performed. With these experiments, we demonstrate that yield of validated EVs varied between different breast cancer cell lines. Protocols were optimized to accommodate for low levels of EVs, and various technical and troubleshooting suggestions are included for potential application to other cell types that may provide benefit to investigators interested in future EV studies.

References

Ng C, Kee L, Al-Masawa M, Lee Q, Subramaniam T, Kok D . Scalable Production of Extracellular Vesicles and Its Therapeutic Values: A Review. Int J Mol Sci. 2022; 23(14). PMC: 9315612. DOI: 10.3390/ijms23147986. View

Duarte-Sanmiguel S, Salazar-Puerta A, Panic A, Dodd D, Francis C, Alzate-Correa D . ICAM-1-decorated extracellular vesicles loaded with miR-146a and drive immunomodulation and hinder tumor progression in a murine model of breast cancer. Biomater Sci. 2023; 11(20):6834-6847. PMC: 10591940. DOI: 10.1039/d3bm00573a. View

Bortot B, Apollonio M, Rampazzo E, Valle F, Brucale M, Ridolfi A . Small extracellular vesicles from malignant ascites of patients with advanced ovarian cancer provide insights into the dynamics of the extracellular matrix. Mol Oncol. 2021; 15(12):3596-3614. PMC: 8637559. DOI: 10.1002/1878-0261.13110. View

Forteza-Genestra M, Antich-Rossello M, Calvo J, Gaya A, Monjo M, Ramis J . Purity Determines the Effect of Extracellular Vesicles Derived from Mesenchymal Stromal Cells. Cells. 2020; 9(2). PMC: 7072280. DOI: 10.3390/cells9020422. View

Welsh J, Goberdhan D, ODriscoll L, Buzas E, Blenkiron C, Bussolati B . Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024; 13(2):e12404. PMC: 10850029. DOI: 10.1002/jev2.12404. View

Gelibter S, Marostica G, Mandelli A, Siciliani S, Podini P, Finardi A . The impact of storage on extracellular vesicles: A systematic study. J Extracell Vesicles. 2022; 11(2):e12162. PMC: 8804350. DOI: 10.1002/jev2.12162. View

Nieuwland R, Siljander P, Falcon-Perez J, Witwer K . Reproducibility of extracellular vesicle research. Eur J Cell Biol. 2022; 101(3):151226. DOI: 10.1016/j.ejcb.2022.151226. View

Andreu Z, Yanez-Mo M . Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014; 5:442. PMC: 4165315. DOI: 10.3389/fimmu.2014.00442. View

Dunlop R, Banack S, Cox P . L1CAM immunocapture generates a unique extracellular vesicle population with a reproducible miRNA fingerprint. RNA Biol. 2023; 20(1):140-148. PMC: 10101655. DOI: 10.1080/15476286.2023.2198805. View

10.

Green T, Alpaugh M, Barsky S, Rappa G, Lorico A . Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype. Biomed Res Int. 2015; 2015:634865. PMC: 4639645. DOI: 10.1155/2015/634865. View

11.

Yanez-Mo M, Siljander P, Andreu Z, Bedina Zavec A, Borras F, Buzas E . Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015; 4:27066. PMC: 4433489. DOI: 10.3402/jev.v4.27066. View

12.

Roux Q, Van Deun J, Dedeyne S, Hendrix A . The EV-TRACK summary add-on: integration of experimental information in databases to ensure comprehensive interpretation of biological knowledge on extracellular vesicles. J Extracell Vesicles. 2020; 9(1):1699367. PMC: 6968489. DOI: 10.1080/20013078.2019.1699367. View

13.

King H, Michael M, Gleadle J . Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer. 2012; 12:421. PMC: 3488584. DOI: 10.1186/1471-2407-12-421. View

14.

Jiang H, Zhao H, Zhang M, He Y, Li X, Xu Y . Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects. Front Immunol. 2022; 13:824188. PMC: 9013908. DOI: 10.3389/fimmu.2022.824188. View

15.

Pan R, He T, Zhang K, Zhu L, Lin J, Chen P . Tumor-Targeting Extracellular Vesicles Loaded with siS100A4 for Suppressing Postoperative Breast Cancer Metastasis. Cell Mol Bioeng. 2023; 16(2):117-125. PMC: 10121989. DOI: 10.1007/s12195-022-00757-5. View

16.

Witwer K, Goberdhan D, ODriscoll L, Thery C, Welsh J, Blenkiron C . Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles. J Extracell Vesicles. 2021; 10(14):e12182. PMC: 8710080. DOI: 10.1002/jev2.12182. View

17.

Medeiros B, Goodale D, Postenka C, Lowes L, Kiser P, Hearn S . Triple-Negative Primary Breast Tumors Induce Supportive Premetastatic Changes in the Extracellular Matrix and Soluble Components of the Lung Microenvironment. Cancers (Basel). 2020; 12(1). PMC: 7016570. DOI: 10.3390/cancers12010172. View

18.

Cao M, Isaac R, Yan W, Ruan X, Jiang L, Wan Y . Cancer-cell-secreted extracellular vesicles suppress insulin secretion through miR-122 to impair systemic glucose homeostasis and contribute to tumour growth. Nat Cell Biol. 2022; 24(6):954-967. PMC: 9233030. DOI: 10.1038/s41556-022-00919-7. View

19.

Shi P, Liu Y, Yang H, Hu B . Breast cancer derived exosomes promoted angiogenesis of endothelial cells in microenvironment via circHIPK3/miR-124-3p/MTDH axis. Cell Signal. 2022; 95:110338. DOI: 10.1016/j.cellsig.2022.110338. View

20.

Bertolini I, Perego M, Ghosh J, Kossenkov A, Altieri D . NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment. Oncogene. 2022; 41(17):2520-2525. PMC: 9040905. DOI: 10.1038/s41388-022-02280-3. View